INTREPID POTASH ($IPI) posted quarterly earnings results for Q4 2025 on Wednesday, March 4th. The company reported earnings of $0.49 per share, beating estimates of $0.33 by $0.16. The company also reported revenue of $62,680,000, missing estimates of $65,902,500 by $-3,222,500.
You can see Quiver Quantitative's $IPI stock page to track data on insider trading, hedge fund activity, congressional trading, and more.
INTREPID POTASH Hedge Fund Activity
We have seen 51 institutional investors add shares of INTREPID POTASH stock to their portfolio, and 91 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- GATE CITY CAPITAL MANAGEMENT, LLC added 705,638 shares (+338.6%) to their portfolio in Q4 2025, for an estimated $19,567,341
- FMR LLC removed 100,356 shares (-94.6%) from their portfolio in Q4 2025, for an estimated $2,782,871
- ARROWSTREET CAPITAL, LIMITED PARTNERSHIP removed 88,476 shares (-88.2%) from their portfolio in Q4 2025, for an estimated $2,453,439
- MILLENNIUM MANAGEMENT LLC removed 67,633 shares (-69.7%) from their portfolio in Q4 2025, for an estimated $1,875,463
- RENAISSANCE TECHNOLOGIES LLC added 67,621 shares (+68.0%) to their portfolio in Q4 2025, for an estimated $1,875,130
- JANE STREET GROUP, LLC removed 59,411 shares (-74.9%) from their portfolio in Q4 2025, for an estimated $1,647,467
- JPMORGAN CHASE & CO removed 57,760 shares (-36.7%) from their portfolio in Q4 2025, for an estimated $1,601,684
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
INTREPID POTASH Analyst Ratings
Wall Street analysts have issued reports on $IPI in the last several months. We have seen 0 firms issue buy ratings on the stock, and 1 firms issue sell ratings.
Here are some recent analyst ratings:
- UBS issued a "Sell" rating on 01/12/2026
To track analyst ratings and price targets for INTREPID POTASH, check out Quiver Quantitative's $IPI forecast page.
This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.
